Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study

Table 2

Prevalence of components of metabolic syndrome among study participants by HIV status.

	Non-HIV controls, n (%)	HAART-naïve HIV patients, n (%)	HAART-treated HIV patients, n (%)
IFG	54 (34.6)	54 (36)	100 (63.3)	<0.001
High systolic BP	84 (53.8)	84 (54.7)	88 (55.7)	0.947
Abdominal obesity	88 (56.4)	68 (45.3)	112 (70.9)	<0.001
Low HDL	36 (23.1)	40 (26.7)	62 (39.2)	0.004
Hypertriglyceridemia	28 (17.9)	30 (20)	82 (51.9)	<0.001

IFG, impaired fasting plasma glucose; BP, blood pressure; HDL, high density lipoprotein cholesterol.